STRATA Skin Sciences, Inc. - Laporan Laba Rugi (TTM)

STRATA Skin Sciences, Inc.
US ˙ NasdaqCM ˙ US86272A2069

Laporan Laba Rugi (TTM)

Laporan Laba Rugi STRATA Skin Sciences, Inc. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 25 23 22 26 28 30 31 33 35 36 37 36 35 33 33 33 33 34 34 33
Change (%) -8.63 -3.91 15.11 8.21 8.47 4.05 5.52 5.17 4.46 1.45 -2.33 -1.57 -5.42 -2.44 0.57 -0.17 2.71 0.17 -2.30
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 10 9 9 9 9 10 11 12 14 14 15 14 15 15 15 15 14 14 14 14
Change (%) -6.24 -2.42 6.35 -0.52 9.53 7.89 13.65 10.30 5.09 1.85 -1.23 1.96 0.91 3.32 -3.83 -2.76 0.60 -3.51 -0.82
% of Revenue 37.80 38.79 39.39 36.39 33.46 33.78 35.03 37.73 39.57 39.80 39.96 40.41 41.86 44.66 47.29 45.22 44.05 43.15 41.56 42.19
Gross Operating Profit 16 14 13 16 18 20 20 20 21 22 22 21 21 18 17 18 18 19 20 19
Change (%) -10.08 -4.85 20.80 13.21 7.93 2.09 1.14 2.06 4.05 1.19 -3.06 -3.96 -9.98 -7.09 4.52 1.97 4.38 2.97 -3.34
% of Revenue 62.20 61.21 60.61 63.61 66.54 66.22 64.97 62.27 60.43 60.20 60.04 59.59 58.14 55.34 52.71 54.78 55.95 56.85 58.44 57.81
SG&A 18 17 18 20 21 23 23 25 25 25 26 25 24 23 23 22 23 24 23 25
Change (%) -7.64 3.93 11.07 7.62 8.45 2.40 5.12 3.66 -0.29 1.54 -2.22 -4.16 -2.88 -3.97 -2.33 6.34 0.81 -0.69 5.10
% of Revenue 72.56 73.35 79.33 76.55 76.13 76.12 74.91 74.62 73.55 70.21 70.27 70.35 68.50 70.34 69.24 67.24 71.62 70.29 69.69 74.96
R&D 1 1 1 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Change (%) 9.45 7.22 11.42 -2.63 -3.24 -15.41 -15.99 -15.21 19.10 14.77 13.97 2.38 -4.43 -5.62 -14.08 -0.47 -16.93 -16.42 -15.31
% of Revenue 4.61 5.52 6.16 5.96 5.36 4.78 3.89 3.10 2.50 2.85 3.22 3.76 3.91 3.95 3.82 3.26 3.25 2.63 2.20 1.90
OpEx 29 27 28 30 32 34 36 38 40 41 42 41 40 40 39 38 39 39 38 39
Change (%) -6.49 1.99 9.60 4.62 8.22 3.27 7.02 5.32 1.97 1.98 -1.41 -1.78 -1.54 -1.29 -3.30 2.60 0.25 -2.09 2.53
% of Revenue 114.96 117.65 124.88 118.90 114.95 114.68 113.83 115.45 115.61 112.86 113.44 114.51 114.26 118.95 120.35 115.73 118.93 116.07 113.44 119.05
Operating Income -4 -4 -6 -5 -4 -4 -4 -5 -5 -5 -5 -5 -5 -6 -7 -5 -6 -5 -5 -6
Change (%) 7.80 35.43 -12.54 -14.42 6.53 -2.02 17.88 6.31 -13.99 6.09 5.43 -3.29 25.67 4.79 -22.29 20.17 -12.79 -16.20 38.45
% of Revenue -14.96 -17.65 -24.88 -18.90 -14.95 -14.68 -13.83 -15.45 -15.61 -12.86 -13.44 -14.51 -14.26 -18.95 -20.35 -15.73 -18.93 -16.07 -13.44 -19.05
Interest Expense -0 -0 -0 -0 -0 -0 -0 -1 -1 -1 -1 -1 -1 -2 -2 -2 -2 -2 -2 -2
Change (%) 75.83 14.22 3.73 12.80 11.35 53.82 37.68 28.72 8.18 9.40 8.88 25.75 18.24 14.51 12.41 0.43 -0.61 -1.80 -1.93
% of Revenue -0.47 -0.91 -1.09 -0.98 -1.02 -1.05 -1.55 -2.02 -2.47 -2.56 -2.76 -3.08 -3.93 -4.92 -5.77 -6.45 -6.49 -6.28 -6.15 -6.18
Net Income -4 -4 -6 -3 -2 -3 -3 -6 -6 -6 -6 -7 -7 -11 -11 -8 -9 -10 -9 -12
Change (%) -1.61 31.35 -47.66 -24.17 17.65 3.10 106.59 8.22 -11.05 6.00 21.35 0.81 50.50 4.92 -26.83 12.86 7.49 -9.28 26.12
% of Revenue -17.74 -19.11 -26.12 -11.88 -8.32 -9.03 -8.94 -17.51 -18.02 -15.35 -16.03 -19.92 -20.40 -32.47 -34.91 -25.40 -28.72 -30.05 -27.22 -35.13

Source: Capital IQ

Other Listings
DE:E2O
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista